🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This case-control study will be conducted between January and June 2026 and...
Status
Enrolling By Invitation
Location
University of babylon
Start Date
2026-01-31
Trial ID
NCT07579338
This study is a prospective study aimed to validate the performance of comb...
Status
Unknown
Location
Fudan university shanghai cancer center, Deparment of gynecologic oncology
Start Date
2023-02-22
Trial ID
NCT06001099
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
The purpose of this study is to identify novel biomarkers of kidney injury ...
Status
Completed
Location
University of Chicago
Start Date
2009-09-22
Trial ID
NCT00984035
Treatments Being Tested
The risk of severe course of SARS-CoV-2 infection in people with Down Syndr...
Status
Unknown
Location
UMC utrecht
Start Date
2021-02-03
Trial ID
NCT05145348
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
The primary objective of this study is to gather stool samples from subject...
Status
Completed
Location
Digestive Health Specialists of the Southeast
Start Date
2014-09
Trial ID
NCT02503696
Treatments Being Tested
The purpose of this study is to collect blood samples from pregnant women w...
Status
Completed
Location
Natera, Inc
Start Date
2012-02
Trial ID
NCT01546324
Treatments Being Tested
Cervical cancer screening (CCS) is important to prevent and control cervica...
Status
Enrolling By Invitation
Location
Unidade Local de Saúde Gaia e Espinho
Start Date
2025-04-10
Trial ID
NCT06915610
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested